{"count": 39, "results": [{"_id": "35910506", "pmid": 35910506, "pmcid": "PMC9326038", "title": "Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation", "journal": "Clin Cosmet Investig Dermatol", "authors": ["Zhang L", "Liu X", "Huang M", "Wang R", "Zhu W", "Li Y", "Shen L", "Li C"], "date": "2022-07-22T00:00:00Z", "doi": "10.2147/CCID.S368845", "meta_date_publication": "2022", "meta_volume": "15", "meta_issue": "", "meta_pages": "1403-1413", "score": 50279.42, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ significantly promoted the autophagy and increase @GENE_FOXO3 @GENE_2309 @@@FOXO3@@@ protein level in the nucleus under @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@. ", "citations": {"NLM": "Zhang L, Liu X, Huang M, Wang R, Zhu W, Li Y, Shen L, Li C. Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation Clin Cosmet Investig Dermatol. 2022;15():1403-1413. PMID: 35910506", "BibTeX": "@article{35910506, title={Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation}, author={Zhang L and Liu X and Huang M and Wang R and Zhu W and Li Y and Shen L and Li C}, journal={Clin Cosmet Investig Dermatol}, volume={15}, pages={1403-1413}}"}}, {"_id": "37110159", "pmid": 37110159, "pmcid": "PMC10142846", "title": "Efficacy Confirmation Test of Black Cumin (Nigella sativa L.) Seeds Extract Using a High-Fat Diet Mouse Model", "journal": "Metabolites", "authors": ["Bashir KMI", "Kim JW", "Kim JK", "Chun YS", "Choi JS", "Ku SK"], "date": "2023-03-30T00:00:00Z", "doi": "10.3390/metabo13040501", "meta_date_publication": "2023 Mar 30", "meta_volume": "13", "meta_issue": "4", "meta_pages": "", "score": 50262.56, "text_hl": "The BCS extract at different doses (400-100 mg/kg) showed a dose-dependent improvement tendency in high-@CHEMICAL_Fats @CHEMICAL_MESH:D005223 @@@fat@@@ diet (HFD)-induced @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@, @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@non-alcoholic fatty liver disease@@@ (@DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@), @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@, and @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@ compared to the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (250 mg/kg). ", "citations": {"NLM": "Bashir KMI, Kim JW, Kim JK, Chun YS, Choi JS, Ku SK. Efficacy Confirmation Test of Black Cumin (Nigella sativa L.) Seeds Extract Using a High-Fat Diet Mouse Model Metabolites. 2023 Mar 30;13(4):. PMID: 37110159", "BibTeX": "@article{37110159, title={Efficacy Confirmation Test of Black Cumin (Nigella sativa L.) Seeds Extract Using a High-Fat Diet Mouse Model}, author={Bashir KMI and Kim JW and Kim JK and Chun YS and Choi JS and Ku SK}, journal={Metabolites}, volume={13}, number={4}}"}}, {"_id": "37646067", "pmid": 37646067, "pmcid": "PMC10460805", "title": "Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19", "journal": "Adv Pharm Bull", "authors": ["Shaseb E", "Ghaffary S", "Garjani A", "Zoghi E", "Maleki Dizaji N", "Soltani S", "Sarbakhsh P", "Somi MH", "Valizadeh P", "Taghizadieh A", "Faghihdinevari M", "Varshochi M", "Naghily B", "Bayatmakoo Z", "Saleh P", "Taghizadeh S", "Haghdoost M", "Owaysi H", "Ravanbakhsh Ghavghani F", "Tarzamni MK", "Moradi R", "Javan Ali Azar F", "Shabestari Khiabani S", "Ghazanchaei A", "Hamedani S", "Hatefi S"], "date": "2023-07-01T00:00:00Z", "doi": "10.34172/apb.2023.066", "meta_date_publication": "2023 Jul", "meta_volume": "13", "meta_issue": "3", "meta_pages": "621-626", "score": 50258.97, "text_hl": "@SPECIES_9606 @@@Patients@@@ receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ prior to the study were not matched for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose and duration. ", "citations": {"NLM": "Shaseb E, Ghaffary S, Garjani A, Zoghi E, Maleki Dizaji N, Soltani S, Sarbakhsh P, Somi MH, Valizadeh P, Taghizadieh A, Faghihdinevari M, Varshochi M, Naghily B, Bayatmakoo Z, Saleh P, Taghizadeh S, Haghdoost M, Owaysi H, Ravanbakhsh Ghavghani F, Tarzamni MK, Moradi R, Javan Ali Azar F, Shabestari Khiabani S, Ghazanchaei A, Hamedani S, Hatefi S. Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19 Adv Pharm Bull. 2023 Jul;13(3):621-626. PMID: 37646067", "BibTeX": "@article{37646067, title={Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19}, author={Shaseb E and Ghaffary S and Garjani A and Zoghi E and Maleki Dizaji N and Soltani S and Sarbakhsh P and Somi MH and Valizadeh P and Taghizadieh A and Faghihdinevari M and Varshochi M and Naghily B and Bayatmakoo Z and Saleh P and Taghizadeh S and Haghdoost M and Owaysi H and Ravanbakhsh Ghavghani F and Tarzamni MK and Moradi R and Javan Ali Azar F and Shabestari Khiabani S and Ghazanchaei A and Hamedani S and Hatefi S}, journal={Adv Pharm Bull}, volume={13}, number={3}, pages={621-626}}"}}, {"_id": "35199116", "pmid": 35199116, "title": "Sargassum fusiforme polysaccharide is a potential auxiliary substance for metformin in the management of diabetes.", "journal": "Food Funct", "authors": ["Wu J", "Jia RB", "Luo D", "Li ZR", "Lin L", "Zheng Q", "Zhao M"], "date": "2022-03-07T00:00:00Z", "doi": "10.1039/d1fo02165f", "meta_date_publication": "2022 Mar 7", "meta_volume": "13", "meta_issue": "5", "meta_pages": "3023-3035", "score": 50249.137, "text_hl": "The results indicate that both @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and LMET-SFP can attenuate body @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ and ameliorate @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@, @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ and @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@, and LMET-SFP exhibited better effects in lowering fasting blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ levels, @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ index and serum @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ only. ", "citations": {"NLM": "Wu J, Jia RB, Luo D, Li ZR, Lin L, Zheng Q, Zhao M. Sargassum fusiforme polysaccharide is a potential auxiliary substance for metformin in the management of diabetes. Food Funct. 2022 Mar 7;13(5):3023-3035. PMID: 35199116", "BibTeX": "@article{35199116, title={Sargassum fusiforme polysaccharide is a potential auxiliary substance for metformin in the management of diabetes.}, author={Wu J and Jia RB and Luo D and Li ZR and Lin L and Zheng Q and Zhao M}, journal={Food Funct}, volume={13}, number={5}, pages={3023-3035}}"}}, {"_id": "37094549", "pmid": 37094549, "title": "Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases.", "journal": "Biomed Pharmacother", "authors": ["Guo HH", "Shen HR", "Wang LL", "Luo ZG", "Zhang JL", "Zhang HJ", "Gao TL", "Han YX", "Jiang JD"], "date": "2023-07-01T00:00:00Z", "doi": "10.1016/j.biopha.2023.114754", "meta_date_publication": "2023 Jul", "meta_volume": "163", "meta_issue": "", "meta_pages": "114754", "score": 50245.418, "text_hl": "We discovered that, although both two drugs had almost identical effects on reducing @DISEASE_Fatty_Liver @DISEASE_MESH:D005234 @@@fatty liver@@@, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@, @CHEMICAL_Berberine @CHEMICAL_MESH:D001599 @@@BBR@@@ appeared to be superior over @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@ in alleviating @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@, but @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@ was more effective than @CHEMICAL_Berberine @CHEMICAL_MESH:D001599 @@@BBR@@@ for the control of @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@. ", "citations": {"NLM": "Guo HH, Shen HR, Wang LL, Luo ZG, Zhang JL, Zhang HJ, Gao TL, Han YX, Jiang JD. Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases. Biomed Pharmacother. 2023 Jul;163():114754. PMID: 37094549", "BibTeX": "@article{37094549, title={Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases.}, author={Guo HH and Shen HR and Wang LL and Luo ZG and Zhang JL and Zhang HJ and Gao TL and Han YX and Jiang JD}, journal={Biomed Pharmacother}, volume={163}, pages={114754}}"}}, {"_id": "39742025", "pmid": 39742025, "title": "Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats.", "journal": "Cardiovasc Ther", "authors": ["Fouladi M", "Mahmoudabady M", "Gholamnezhad Z", "Shabab S", "Niazmand S", "Salmani H"], "date": "2024-07-09T00:00:00Z", "doi": "10.1155/2024/6025911", "meta_date_publication": "2024", "meta_volume": "2024", "meta_issue": "", "meta_pages": "6025911", "score": 50240.664, "text_hl": "It seems that exercise along with taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can be considered as a therapeutic method by improving @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and reducing oxidative stress and vascular @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ responses, leading to ameliorating biomarkers function related to @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial damage@@@ in experimental @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ conditions.", "citations": {"NLM": "Fouladi M, Mahmoudabady M, Gholamnezhad Z, Shabab S, Niazmand S, Salmani H. Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats. Cardiovasc Ther. 2024;2024():6025911. PMID: 39742025", "BibTeX": "@article{39742025, title={Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats.}, author={Fouladi M and Mahmoudabady M and Gholamnezhad Z and Shabab S and Niazmand S and Salmani H}, journal={Cardiovasc Ther}, volume={2024}, pages={6025911}}"}}, {"_id": "39871590", "pmid": 39871590, "title": "Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.", "journal": "Skinmed", "authors": ["Al-Qarqaz FA", "Marji MM"], "date": "2024-12-31T00:00:00Z", "meta_date_publication": "2024", "meta_volume": "22", "meta_issue": "6", "meta_pages": "472-474", "score": 50235.08, "text_hl": "Her medical conditions included @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@, @DISEASE_Vitamin_D_Deficiency @DISEASE_MESH:D014808 @@@vitamin D deficiency@@@, and @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@. Her treatment for the past 4 years included @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_saxagliptin @CHEMICAL_MESH:C502994 @@@saxagliptin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_Vitamin_B_12 @CHEMICAL_MESH:D014805 @@@vitamin B12@@@, @CHEMICAL_Vitamin_D @CHEMICAL_MESH:D014807 @@@vitamin D@@@, @CHEMICAL_Lansoprazole @CHEMICAL_MESH:D064747 @@@lansoprazole@@@, and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@. ", "citations": {"NLM": "Al-Qarqaz FA, Marji MM. Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent. Skinmed. 2024;22(6):472-474. PMID: 39871590", "BibTeX": "@article{39871590, title={Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.}, author={Al-Qarqaz FA and Marji MM}, journal={Skinmed}, volume={22}, number={6}, pages={472-474}}"}}, {"_id": "35947843", "pmid": 35947843, "title": "Hypoglycemic, Hypolipidemic and Antioxidant Potentials of Ethanolic Stem Bark Extract of Anacardium occidentale in Streptozotocin-Induced Diabetic Rats.", "journal": "Niger J Physiol Sci", "authors": ["Bamisaye FA", "Ibrahim RA", "Sulyman AO", "Jubril AO", "Ajuwon O"], "date": "2022-06-30T00:00:00Z", "doi": "10.54548/njps.v37i1.17", "meta_date_publication": "2022 Jun 30", "meta_volume": "37", "meta_issue": "1", "meta_pages": "137-145", "score": 50234.555, "text_hl": "Results showed that treatment with 200 and 400 mg/kg Anacardium occidentale stem bark extract reversed @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ induced by @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@STZ@@@ similar to what was observed with the standard drug, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Bamisaye FA, Ibrahim RA, Sulyman AO, Jubril AO, Ajuwon O. Hypoglycemic, Hypolipidemic and Antioxidant Potentials of Ethanolic Stem Bark Extract of Anacardium occidentale in Streptozotocin-Induced Diabetic Rats. Niger J Physiol Sci. 2022 Jun 30;37(1):137-145. PMID: 35947843", "BibTeX": "@article{35947843, title={Hypoglycemic, Hypolipidemic and Antioxidant Potentials of Ethanolic Stem Bark Extract of Anacardium occidentale in Streptozotocin-Induced Diabetic Rats.}, author={Bamisaye FA and Ibrahim RA and Sulyman AO and Jubril AO and Ajuwon O}, journal={Niger J Physiol Sci}, volume={37}, number={1}, pages={137-145}}"}}, {"_id": "34168429", "pmid": 34168429, "pmcid": "PMC8218939", "title": "Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats", "journal": "Drug Des Devel Ther", "authors": ["Zou W", "Zhang C", "Gu X", "Li X", "Zhu H"], "date": "2021-06-17T00:00:00Z", "doi": "10.2147/DDDT.S307257", "meta_date_publication": "2021", "meta_volume": "15", "meta_issue": "", "meta_pages": "2565-2576", "score": 50234.465, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@GENE_MET @GENE_24553 @@@MET@@@) is the most prescribed oral @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@anti-diabetic drug@@@ and derived from plant @SPECIES_47101 @@@Galega officinalis@@@. ", "citations": {"NLM": "Zou W, Zhang C, Gu X, Li X, Zhu H. Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats Drug Des Devel Ther. 2021;15():2565-2576. PMID: 34168429", "BibTeX": "@article{34168429, title={Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats}, author={Zou W and Zhang C and Gu X and Li X and Zhu H}, journal={Drug Des Devel Ther}, volume={15}, pages={2565-2576}}"}}, {"_id": "9888646", "pmid": 9888646, "title": "Effects of fibric acid derivatives and metformin on postprandial lipemia.", "journal": "Atherosclerosis", "authors": ["Weintraub MS", "Charach G", "Grosskopf I"], "date": "1998-12-01T00:00:00Z", "doi": "10.1016/s0021-9150(98)00221-4", "meta_date_publication": "1998 Dec", "meta_volume": "141 Suppl 1", "meta_issue": "", "meta_pages": "S71-5", "score": 50072.49, "text_hl": "Effects of @CHEMICAL_fibric_acid @CHEMICAL_MESH:C010285 @@@fibric acid@@@ derivatives and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on postprandial @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@lipemia@@@.", "citations": {"NLM": "Weintraub MS, Charach G, Grosskopf I. Effects of fibric acid derivatives and metformin on postprandial lipemia. Atherosclerosis. 1998 Dec;141 Suppl 1():S71-5. PMID: 9888646", "BibTeX": "@article{9888646, title={Effects of fibric acid derivatives and metformin on postprandial lipemia.}, author={Weintraub MS and Charach G and Grosskopf I}, journal={Atherosclerosis}, volume={141 Suppl 1}, pages={S71-5}}"}}]}